Entrada Therapeutics TRDA Balance Sheet (2020-2026)

NASDAQ TRDA
$5.44 +0.19 (+3.62%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Entrada Therapeutics Quarterly Balance Sheet

Periods 25 quarters
Latest Sep 2026

Entrada Therapeutics reported total assets of $266.88M and total liabilities of $68.56M for the quarter ended Sep 2026, down 35.4% year over year. This balance sheet covers 25 quarters of results from Sep 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
291.06M84.64M90.87M53.31M45.16M227.65M79.74M51.88M67.60M68.44M185.25M78.05M101.21M67.84M72.48M93.29M90.39M76.44M99.28M112.24M
Short-term InvestmentsInvestments (Current)
179.26M153.39M162.26M
Cash & Current Investments
291.06M263.90M244.25M215.57M45.16M227.65M79.74M51.88M67.60M68.44M185.25M78.05M101.21M67.84M72.48M93.29M90.39M76.44M99.28M112.24M
Receivables - NetNet Receivables
6.30M3.74M5.03M5.88M77.51M7.67M2.60M3.68M2.04M1.18M1.20M1.18M0.79M0.82M0.84M
Receivables
6.30M3.74M5.03M5.88M77.51M7.67M2.60M3.68M2.04M1.18M1.20M1.18M0.79M0.82M0.84M
Prepaid Assets
7.64M8.81M9.65M19.16M21.16M16.21M9.66M24.44M11.92M9.24M12.12M13.39M16.36M18.63M13.95M10.22M8.72M11.23M8.88M9.10M
Current Assets
298.70M272.71M253.90M234.73M209.88M434.14M390.20M383.04M369.77M414.17M489.54M465.34M440.04M403.19M369.15M338.26M306.25M266.87M232.70M202.95M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
6.26M7.20M7.79M7.44M7.68M9.39M11.02M11.04M11.19M11.00M11.34M10.79M10.93M10.67M9.81M8.41M7.31M6.51M5.72M5.21M
Other Non-Current Assets
0.87M9.33M8.78M8.85M9.16M17.79M4.49M6.93M6.74M6.71M4.70M4.70M4.28M4.19M4.15M4.11M3.36M3.38M3.41M3.42M
Non-Current Assets
7.13M43.99M42.01M39.73M42.18M41.43M103.79M101.99M99.42M96.67M92.43M89.26M86.28M83.29M79.64M74.64M71.13M68.65M66.17M63.93M
Assets
305.83M316.70M295.92M274.46M252.06M475.57M493.98M485.03M469.19M510.84M581.96M554.59M526.32M486.48M448.78M412.90M377.38M335.52M298.88M266.88M
Liabilities
Current Liabilities
Accounts Payables
0.71M2.93M4.62M1.34M5.99M6.47M2.42M0.75M3.28M2.53M1.64M1.29M4.26M2.19M1.86M3.17M2.29M2.93M3.75M4.87M
Payables
0.71M2.93M4.62M1.34M5.99M6.47M2.42M0.75M3.28M2.53M1.64M1.29M4.26M2.19M1.86M3.17M2.29M2.93M3.75M4.87M
Accumulated Expenses
6.01M4.52M5.34M11.95M7.58M11.68M7.11M9.60M11.33M8.79M11.00M13.40M13.34M7.58M11.80M15.53M17.68M11.73M13.00M16.28M
Other Accumulated Expenses
0.49M
Current Leases
7.97M8.11M8.26M8.41M7.10M7.41M6.64M7.91M8.30M8.57M7.74M7.56M6.51M5.46M4.35M4.14M4.28M4.45M4.62M
Current Taxes
7.36M4.02M5.86M4.11M2.25M0.67M0.80M0.62M
Current Deferred Revenue
122.34M101.65M148.44M132.26M148.46M60.50M45.92M13.65M1.35M0.69M0.35M0.34M0.25M0.17M0.10M
Total Current Liabilities
6.72M15.43M18.08M21.55M21.97M147.59M125.94M165.43M158.80M173.94M85.81M70.60M39.48M18.43M19.80M24.02M24.45M19.20M21.37M25.86M
Non-Current Liabilities
Non-Current Deferred Revenue
89.24M95.51M10.51M7.72M9.41M10.35M7.96M6.51M0.30M0.19M0.11M
Preferred Stock Liabilities
Operating Leases
23.89M21.80M19.69M17.53M9.12M65.62M62.43M60.32M58.13M55.88M53.58M51.65M50.49M49.28M48.05M46.79M45.47M44.10M42.69M
Other Non-Current Liabilities
0.40M
Total Non-Current Liabilities
6.72M39.31M39.88M
Total Liabilities
7.12M39.31M39.88M41.24M39.50M245.96M287.08M238.37M226.83M241.48M152.04M132.14M97.64M69.22M69.28M72.18M71.25M64.66M65.47M68.56M
Shareholder's Equity
Common Equity
298.72M277.39M256.04M233.22M212.55M229.61M206.91M246.66M242.36M269.37M429.93M422.45M428.68M417.26M379.51M340.72M306.13M270.85M233.41M198.33M
Liabilities and Shareholders Equity
305.83M316.70M295.92M274.46M252.06M475.57M493.98M485.03M469.19M510.84M581.96M554.59M526.32M486.48M448.78M412.90M377.38M335.52M298.88M266.88M
Retained Earnings
-93.67M-115.34M-138.52M-163.70M-188.29M-195.00M-220.90M-185.43M-194.97M-171.50M-116.44M-130.50M-129.34M-146.70M-189.80M-233.93M-273.09M-312.81M-355.60M-395.32M

Entrada Therapeutics Balance Sheet API

Pull Entrada Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TRDA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY